Market Overview:
The global penicillamine market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of rheumatoid arthritis and other autoimmune diseases, increasing demand for generic drugs, and growing awareness about the benefits of penicillamine therapy. Based on type, the global penicillamine market is segmented into capsule and tablet. The capsule segment is expected to account for a larger share of the market in 2018 owing to its ease of use and higher patient compliance rates as compared to tablets. Based on application, the global penicillamine market is segmented into hospitals, drug stores, and others (including clinics). The hospitals segment accounted for a larger share of the market in 2017 due to rising demand for this drug from patients with rheumatoid arthritis and other autoimmune diseases.
Product Definition:
Penicillamine is an amino acid used to treat Wilson's disease, cystinuria, and rheumatoid arthritis. It helps remove copper and other metals from the body, and it reduces inflammation.
Penicillamine Capsule:
Penicillamine capsules are used for the treatment of secondary syphilis and tertiary syphilis. They work by killing the bacteria that cause the infection. It is most commonly prescribed to patients who have been exposed to other forms of antibiotics but do not develop full blown infections after exposure.
Penicillamine Tablet:
Penicillamine tablet is a white crystalline compound, which is odorless. It has a slightly bitter taste. It is soluble in water and alcohol and slightly soluble in ether. Penicillamine can be administered orally as well as topically for the treatment of infections due to susceptible bacteria (Gram-positive & -negative).
Application Insights:
The drug is used for the treatment of various diseases such as rheumatoid arthritis, osteoarthritis, gouty arthritis, lupus erythematosus and others. The disease conditions mentioned above are mainly caused due to the inflammation of the body¢â‚¬â„¢s immune system. As per a research study published in 2017 by National Center for Biotechnology Information (NCBI) around 4 out of 5 people aged 65 years or above suffer from some form of arthritis. Therefore, penicillamine market is anticipated to be high in demand among patients suffering from these aforementioned arthritides over the forecast period owing to its low cost and effectiveness compared with conventional anti-inflammatory drugs such as aspirin and ibuprofen which have more side effects on long term use.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to high awareness levels regarding early diagnosis of diseases, availability of effective treatment options, and rising healthcare expenditure by governments as well as consumers. In addition, increasing prevalence of rheumatoid arthritis and other autoimmune disorders is anticipated to drive demand for Penicillamine Tablets in North America over the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing to improving healthcare infrastructure coupled with growing investments by governments and private players in this region. Moreover, economic development coupled with rise in disposable income will boost demand for medicines such as Penicillamine Capsule/Tablet leading to an increase CAGR during the projected time frame in Asia Pacific penicillamine market’s growth rate being second only behind North America).
Growth Factors:
- Increasing incidence of rheumatoid arthritis and other autoimmune diseases: The global prevalence of rheumatoid arthritis is estimated to be around 1%–2%. The disease is more common in women than men. It is also more prevalent in developed countries. The increasing incidence of autoimmune diseases such as rheumatoid arthritis, lupus, and Sjögren’s syndrome is expected to drive the growth of the penicillamine market.
- Rising awareness about the benefits of early diagnosis and treatment: There is a growing awareness among patients about the benefits of early diagnosis and treatment for autoimmune diseases such as rheumatoid arthritis. This is likely to drive demand for penicillamine products in the coming years.
- Growing number of product approvals: The number of product approvals for treating various autoimmune diseases has been increasing over the past few years, which will help boost demand for penicillamine products in this market segment. For instance, In February 2017, Zydus Cadila received approval from Drug Controller General (India) (DCGI) for its generic version ocrelizumab injection used to treat multiple sclerosis (MS). This will help expand access to this drug across India and other emerging markets in Asia Pacific region..
Scope Of The Report
Report Attributes
Report Details
Report Title
Penicillamine Market Research Report
By Type
Penicillamine Capsule, Penicillamine Tablet
By Application
Hospitals, Drugs Store, Others
By Companies
Bausch Health, Teva, Endo International, Ani Pharma, Apotex, Sine Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Penicillamine Market Report Segments:
The global Penicillamine market is segmented on the basis of:
Types
Penicillamine Capsule, Penicillamine Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Drugs Store, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Teva
- Endo International
- Ani Pharma
- Apotex
- Sine Pharma
Highlights of The Penicillamine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Penicillamine Capsule
- Penicillamine Tablet
- By Application:
- Hospitals
- Drugs Store
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Penicillamine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Penicillamine is a medication used to treat certain types of anemia. It works by helping your body produce more red blood cells.
Some of the major players in the penicillamine market are Bausch Health, Teva, Endo International, Ani Pharma, Apotex, Sine Pharma.
The penicillamine market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Penicillamine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Penicillamine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Penicillamine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Penicillamine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Penicillamine Market Size & Forecast, 2020-2028
4.5.1 Penicillamine Market Size and Y-o-Y Growth
4.5.2 Penicillamine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Penicillamine Capsule
5.2.2 Penicillamine Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Drugs Store
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Penicillamine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Penicillamine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Penicillamine Capsule
9.6.2 Penicillamine Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Drugs Store
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Penicillamine Capsule
10.6.2 Penicillamine Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Drugs Store
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Penicillamine Capsule
11.6.2 Penicillamine Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Drugs Store
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Penicillamine Capsule
12.6.2 Penicillamine Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Drugs Store
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Penicillamine Capsule
13.6.2 Penicillamine Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Drugs Store
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Penicillamine Market: Competitive Dashboard
14.2 Global Penicillamine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Teva
14.3.3 Endo International
14.3.4 Ani Pharma
14.3.5 Apotex
14.3.6 Sine Pharma
